Natixis’s PhenomeX Inc. Common Stock CELL Stock Holding History

Natixis’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,044	Closed	-$83K	–	1202
2022 Q2	$83K	Sell	17,044 -6,822	-29%	-$35.7K	﹤0.01%	1062
2022 Q1	$170K	Sell	23,866 -1,623	-6%	-$13.4K	﹤0.01%	1112
2021 Q4	$463K	Sell	25,489 -1,127	-4%	-$24.3K	﹤0.01%	1047
2021 Q3	$521K	Sell	26,616 -1,947	-7%	-$74K	﹤0.01%	1008
2021 Q2	$1.28M	Buy	+28,563	New	+$1.32M	0.01%	585

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Natixis's CELL Position: Q3 2022 in Review

Natixis sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 17,044 shares — an estimated $83K sold.

Natixis first reported a position in CELL in Q2 2021 and held it in 5 quarters. The position peaked at $1.28M in Q2 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

Natixis reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Natixis sold 17,044 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $83K.
Natixis first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Natixis's PhenomeX Inc. Common Stock position peaked at $1.28M in Q2 2021.
113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Natixis's 13F filing for Q3 2022, filed 14 Nov 2022.